Recent advances in particle engineering for pharmaceutical applications

American Pharmaceutical Review

Volumn 14, Issue 2, 2011, Pages 98-103

  Parikh, Dilip M ^a  

^a DPharma Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

AEROSOL; BIOCHEMISTRY; CONDUCTANCE; DENSITY; DRUG BIOAVAILABILITY; DRUG MANUFACTURE; DRUG SOLUBILITY; MORPHOLOGY; PARTICLE ENGINEERING; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; SIZE REDUCTION; SPRAY DRYING;

EID: 79953236761     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. V. Swaminathan and D. O. Kildsig. Polydisperse powder vmixtures: effect of particle size and shape on mixture stability. Drug Dev. Ind. Pharm. 28:41Y48 (2002).
2. T. Shiraishi, A. Sano, S. Kondo, H. Yuasa, and Y. Kanaya Studies on the granulation process of granules for tableting with a high speed mixer. II. Influence of particle size of active substance on granulation. Chem. Pharm. Bull. 43: 654Y659 (1995).
3. T. Yajima, S. Itai, H. Hayashi, K. Takayama, and T. Nagai. Optimization of size distribution of granules for tablet compression. Chem. Pharm. Bull. 44:1056Y1060 (1996).
4. T. Yao, M. Yamada, H. Yamahara, and M. Yoshida. Tableting of coated particles. II. Influence of particle size of pharmaceutical additives on protection of coating membrane from mechanical damage during compression process. Chem. Pharm. Bull. 46:826Y830 (1998).
5. C. Sun and D. J. W. Grant. Influence of crystal shape on the tableting performance of l-lysine monohydrochloride dihydrate. J. Pharm. Sci. 90:569Y579 (2001).
6. S. Simoes, A. Sousa, and M. Figueiredo. Dissolution rate studies of pharmaceutical multisized powdersVa practical approach using the Coulter method. Int. J. Pharm. 127: 283Y291 (1996).
7. J. B. Bressman and C. Reppas. In vitroYin vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11 (Suppl. 2):S73YS80 (2000).
8. S. Horkovics-Kovats. Characterization of an active pharmaceutical ingredient by its dissolution properties: amoxicillin trihydrate as a model drug. Chemotherapy 50:234Y244 (2004).
9. H. Hu, K. P. Johnston, and R. O. Williams III. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev. Ind. Pharm. 30:233Y245 (2004).
10. J. Siepmann, H. Kranz, N. A. Peppas, and R. Bodmeier. Calculation of the required size and shape of hydroxypropylmethylcellulose matrices to achieve desired drug release profiles. Int. J. Pharm. 201:151Y164 (2000).
11. H.L. Goldsmith, V.T. Turitto, Rheological aspects of thrombosis and hemostasis - basic principles and applications - Icth-Report - Subcommittee on Rheology of the International Committee on Thrombosis and Hemostasis, Thromb. Haemost. 55 (3) (1986) 415-435.
12. V.R.S. Patil, C.J. Campbell, Y.H. Yun, S.M. Slack, D.J. Goetz, Particle diameter influences adhesion under flow, Biophys. J. 80 (4) (2001) 1733-1743. (Pubitemid 32280989)
13. A. Lamprecht, U. Schafer, C.M. Lehr, Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa, Pharm. Res. 18 (6) (2001) 788-793.
14. B. E. Rabinow. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 3:785Y796 (2004).
15. B. E. Rabinow. Pharmacokinetics of nanosuspensions. Presentation at Nanotechnology for Drug Delivery Conference, Philadelphia, PA (2005).
16. A. Rolland. Particulate carriers in dermal and transdermal drug delivery: myth or reality? In: A. Rolland (ed.), Pharmaceutical Particulate Cariiers Therapeutic Applications, Marcel Dekker, New York, 1993, pp. 367-421.]
17. L. Illum, S.S. Davis, C.G. Wilson, N.W. Thomas, M. Frier, J.G. Hardy, Blood clearance and organ deposition of intravenously administered colloidal particles - the effects of particle size, nature and shape, Int. J. Pharm. 12 (2-3) (1982) 135-146. (Pubitemid 12037337)
18. Y. Tabata, Y. Ikada, Phagocytosis of polymer microspheres by macrophages, Adv. Polym. Sci. 94 (1990) 107-141.
19. S.M. Moghimi, A.C. Hunter, J.C. Murray, Long-circulating and targetspecific nanoparticles: theory to practice, Pharm. Rev. 53 (2) (2001) 283-318.
20. Masters K. Spray drying fundamentals: process stages and layouts. Spray Drying Handbook. 5th ed. Essex, UK: Longman Scientific Technical,1991: 43.
21. Wendell SC, Çelik M., An overview of spray-drying applications. Pharm Technol 1997: 21(10), 124-156.
22. Parikh DM. Advances in spray drying technology: New applications for a proven process. Am. Phar. Rev 2008: 11(1), 34-41
23. Celik, M and Wendell SC, " Spray drying and pharmaceutical applications" Chapter 5 page 98-125 in Handbook of Pharmaceutical Granulation Technology 3rd Edition", Parikh DM(Editor) 2009 Informa Helath (Publisher)
24. [Costantino HR, Firouzabadian L, Wu C, Carrasquillo KG, Griebenow K, Zale SE, Tracy MA ".Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability." J Pharm Sci. 2002 Feb;91(2):388-95.
25. Thassu D, Pathak Y., Delwwrs m, " Pharmaceutical Applications of Nanoengineering" Chapter 7 Pages 138-162 in "Handbook of Pharmaceutical Granulation Technology 3rd Edition" , Parikh DM(Editor) 2009 Informa Helath (Publisher)
26. Mehnert W, Mader K. SolidCrossed D signlipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001; 40:165.
27. Jung J, Perrut M. Particle design using supercritical fluids: Literature and patent survey. J Supercrit Fluids 2001, 20 (3), 179-219. (Pubitemid 32607129)
28. E. Reverchon, G. Della Porta, R. Taddeo, P. Pallado, A. Stassi. Ind. Eng. Chem. Res. 34, 4087 (1995).
29. P. G. Debenedetti, J. W. Tom, S. D. Yeo, G. B. Lim. J. Controlled Release 24, 27 (1993).
30. P. G. Debenedetti. J. Supercrit. Fluids 7, 9 (1994).
31. J. Kim, T. Paxton, D. Tomasko. Biotechnol. Prog. 12, 650 (1996).
32. Martin Wahl, "Supercritical Fluid Technology" Chapter 6 p 126-137 in Handbook of Pharmaceutical Granulation Technology" 3rd edition (D M. Parikh (editor) 2009 Informa Healthe (Publisher)
33. J. Kerc, S. Srcic, Z. Knez, P. Sencar-Bozic. Int. J. Pharmac. 182, 33 (1999).
34. P. Sencar-Bozic, S. Srcic, Z. Knez, J. Kerc. Int. J. Pharmac. 148, 123 (1997).
35. FOSTER, Neil, Russell; PENG TZE SIH, Roderick; Patent: .WO/2008/040094 International Application No.: PCT/AU2007/001515 Publication Date: 10.04.2008 International Filing Date: 05.10.2007]